SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-056810
Filing Date
2021-11-15
Accepted
2021-11-15 07:45:34
Documents
14
Period of Report
2021-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bdsx-8k_20211115.htm   iXBRL 8-K 32795
2 EX-99.1 bdsx-ex991_6.htm EX-99.1 327029
3 GRAPHIC go5ailyhn2f3000001.jpg GRAPHIC 2857
  Complete submission text file 0001564590-21-056810.txt   511183

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bdsx-20211115.xsd EX-101.SCH 5669
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsx-20211115_lab.xml EX-101.LAB 20069
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsx-20211115_pre.xml EX-101.PRE 11922
7 EXTRACTED XBRL INSTANCE DOCUMENT bdsx-8k_20211115_htm.xml XML 3680
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

IRS No.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39659 | Film No.: 211406375
SIC: 8071 Services-Medical Laboratories